| Dr Danielle Marie Mire, MD, MSED | |
|
819 Mount Tabor Rd, Suite 2, New Albany, IN 47150-6414 | |
| (812) 590-3385 | |
| (812) 590-3373 |
| Full Name | Dr Danielle Marie Mire |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 819 Mount Tabor Rd, New Albany, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508037136 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danielle Marie Mire, MD, MSED 819 Mount Tabor Rd, Suite 2, New Albany, IN 47150-6414 Ph: (812) 590-3385 | Dr Danielle Marie Mire, MD, MSED 819 Mount Tabor Rd, Suite 2, New Albany, IN 47150-6414 Ph: (812) 590-3385 |
News Archive
Researchers used the placebo effect to successfully treat psoriasis patients with one quarter to one half of their usual dose of a widely used steroid medication, according to an early study published online today in the journal Psychosomatic Medicine.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced that additional data will be presented from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
Kids with Pompe disease fail because of a missing enzyme, GAA, that leads to dangerous sugar build-up, which affects muscles and movement. An enzyme replacement treatment pioneered at Duke University has saved many lives, but some children with Pompe disease produce an immune reaction that blocks the benefits of the life-saving enzyme treatment.
Athletes increasingly relying on a coach over the course of a season may be a sign that they aren't progressing in their development, according to new research from Binghamton University.
Eisai Inc. announced today preliminary results from a randomized Phase III clinical trial of Dacogen® (decitabine) for Injection versus either a low-dose chemotherapy agent or supportive care in elderly patients with acute myeloid leukemia (AML), a life-threatening cancer of the blood that generally occurs in older adults.
› Verified 6 days ago
Therese Marie Keeling, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4925 Charlestown Rd, New Albany, IN 47150 Phone: 812-941-9200 Fax: 812-941-9205 | |
Dr. John W Melton, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1850 State St, New Albany, IN 47150 Phone: 502-899-1193 Fax: 502-897-7233 | |
Dr. Ross E. Nunes, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 720 Rolling Creek Dr Ste 101, New Albany, IN 47150 Phone: 812-920-0122 Fax: 812-920-0124 | |
Vishnumurthy Shushrutha Hedna, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1850 State St, New Albany, IN 47150 Phone: 812-944-7701 Fax: 812-981-6505 | |
Dr. Akif M Hasan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1919 State St Ste 305, New Albany, IN 47150 Phone: 812-944-0367 Fax: 812-944-1279 | |
Dr. Cameron S Luo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5120 Charleston Road, Suite #5, New Albany, IN 47150 Phone: 812-725-8621 Fax: 812-725-8696 |